Padmanabh P. Bhatt is CSO & VP at SUPERNUS PHARMACEUTICALS, INC. (SUPN). They have made 24 open-market trades across 1 company since 2013, most recently 2026-08-12.
CIK 0001539215
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 24 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SUPN | 18,637 | $706K |
Shares reported on the most recent Form 4, priced at the 2026-08-14 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SUPN | SELL · 10b5-1 | 2026-03-16 | 2026-03-18 | $50.24 | $5.4M | +0.6% | +4.8% | -11.3% |
| SUPN | SELL | 2025-12-18 | 2025-12-19 | $44.44 | $32K | -3.7% | -3.0% | -4.9% |
| SUPN | SELL | 2025-02-04 | 2025-02-05 | $39.70 | $752K | +1.0% | -18.5% | -17.6% |
| SUPN | SELL | 2025-01-27 | 2025-01-29 | $39.62 | $232K | -3.7% | -18.6% | -17.5% |
| SUPN | SELL | 2024-12-03 | 2024-12-04 | $36.68 | $1.3M | -0.9% | +0.2% | -14.1% |
| SUPN | SELL · 10b5-1 | 2024-03-21 | 2024-03-25 | $35.31 | $1.0M | +1.7% | -8.3% | -18.4% |
| SUPN | SELL · 10b5-1 | 2024-03-20 | 2024-03-22 | $35.31 | $14K | -4.3% | -14.5% | -22.8% |
| SUPN | SELL · 10b5-1 | 2024-03-19 | 2024-03-21 | $35.31 | $873K | -3.7% | -15.5% | -23.8% |
| SUPN | SELL · 10b5-1 | 2024-03-13 | 2024-03-15 | $33.65 | $3.3M | +1.8% | -9.5% | -19.9% |
| SUPN | SELL · 10b5-1 | 2024-03-12 | 2024-03-14 | $32.99 | $256K | -1.7% | -9.2% | -18.0% |
| SUPN | SELL · 10b5-1 | 2024-02-26 | 2024-02-28 | $30.21 | $151K | +3.6% | +7.1% | -13.5% |
| SUPN | SELL | 2023-01-17 | 2023-01-19 | $39.92 | $385K | +1.4% | -4.0% | -8.0% |
| SUPN | SELL · 10b5-1 | 2023-01-06 | 2023-01-09 | $39.90 | $7K | +4.5% | -0.7% | -3.2% |
| SUPN | SELL | 2022-12-01 | 2022-12-02 | $37.48 | $375K | -1.8% | +3.4% | +10.0% |
| SUPN | SELL | 2022-11-11 | 2022-11-15 | $34.95 | $475K | +4.5% | +4.1% | +15.8% |
| SUPN | SELL · 10b5-1 | 2022-11-09 | 2022-11-14 | $34.97 | $24K | +0.9% | +1.9% | +13.0% |
| SUPN | SELL | 2018-06-28 | 2018-06-29 | $59.92 | $934K | -10.1% | -11.2% | -16.3% |
| SUPN | SELL | 2018-06-21 | 2018-06-22 | $60.00 | $432K | -9.5% | -2.2% | -11.8% |
| SUPN | SELL | 2018-05-15 | 2018-05-16 | $57.93 | $456K | -4.1% | -6.0% | -26.9% |
| SUPN | SELL | 2018-05-11 | 2018-05-14 | $54.49 | $2.6M | -1.3% | -4.2% | -22.9% |
| SUPN | SELL | 2018-05-10 | 2018-05-14 | $53.53 | $4.5M | -1.3% | -4.2% | -22.9% |
| SUPN | SELL | 2018-05-10 | 2018-05-14 | $49.88 | $998K | -1.3% | -4.2% | -22.9% |
| SUPN | SELL | 2018-01-22 | 2018-01-22 | $48.04 | $961K | -8.7% | -14.6% | +6.5% |
| SUPN | SELL | 2018-01-17 | 2018-01-17 | $44.98 | $1.8M | -10.9% | -16.7% | +0.7% |
| SUPN | SELL | 2017-09-08 | 2017-09-11 | $49.86 | $249K | -18.4% | -14.7% | -21.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.